Canurta Therapeutics
Canurta Therapeutics develops botanical therapeutics derived from novel polyphenols to target neuroinflammation and degenerative conditions. The company’s research focuses on cannabis-based polyphenols such as cannflavins A and B, bibenzyls, and stilbenes, which show potential in addressing the underlying mechanisms of inflammatory and neurological diseases. Using proprietary extraction and enrichment technologies, it isolates and studies these compounds to better understand their therapeutic applications. Its work combines advanced pharmacological analysis with data-driven development to explore alternative mechanisms of action beyond traditional anti-inflammatory pathways. Its approach supports the discovery and development of therapeutic candidates for long-term disease modification.
Canurta Therapeutics
Canurta Therapeutics develops botanical therapeutics derived from novel polyphenols to target neuroinflammation and degenerative conditions. The company’s research focuses on cannabis-based polyphenols such as cannflavins A and B, bibenzyls, and stilbenes, which show potential in addressing the underlying mechanisms of inflammatory and neurological diseases. Using proprietary extraction and enrichment technologies, it isolates and studies these compounds to better understand their therapeutic applications. Its work combines advanced pharmacological analysis with data-driven development to explore alternative mechanisms of action beyond traditional anti-inflammatory pathways. Its approach supports the discovery and development of therapeutic candidates for long-term disease modification.